{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-038305","form_type":"8-K","ticker":"FEED","cik":"0001326706","company_name":"ENvue Medical, Inc.","filed_at":"2026-08-14T20:06:09+00:00","discovered_at":"2026-08-14T20:12:00.474959+00:00","generated_at":"2026-08-14T20:12:07.832126+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ENvue Medical stockholders approve reverse stock split ratio range 1-for-2 to 1-for-50","bullets":["Stockholders approved reverse stock split: 3,847,974 for, 1,062,981 against, 19,288 abstain.","Board authorized to set ratio between 1-for-2 and 1-for-50, to be announced publicly, within one year.","Adjournment proposal passed (4,199,681 for) but not needed; no motion made.","Special meeting held Aug 14, 2026; no other matters voted on."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-038305","json":"https://secwatch.observer/filing/0001493152-26-038305.json","markdown":"https://secwatch.observer/filing/0001493152-26-038305.md","text":"https://secwatch.observer/filing/0001493152-26-038305.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326706/000149315226038305/0001493152-26-038305-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326706/000149315226038305/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-14T20:12:07.832126+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}